Chances unlikely for Trans-Pacific trade pact by April; Japan's Eisai launches anticancer therapy Lenvima in U.S.;

> Japan's Olympus is making a two-year push to train Thai doctors on laparoscopic equipment. Story

> China's Cisen Pharmaceutical teamed up with Georgia State University on anticancer compounds. Release

> Jim Li has been named as CEO successor at China's Sundia as current head Chen Chen retires. Release

> Chances seen as unlikely for nations to hammer out Trans-Pacific Partnership pact before April. Story

> India launched an effort to eliminate Elephantiasis with 1.3 million affected. Story

> U.S. FDA approved India's Jubilant Life on generic asthma tablets. Story

> Japan's Eisai launched Lenvima anticancer therapy in U.S. as first market. Story